Jefferies Financial Group Inc. Abbott Laboratories Put Options Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $2.01 Million - $2.46 Million	-22,300 Reduced 49.78%	22,500 $2.48 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $2.29 Million - $2.75 Million	24,000 Added 115.38%	44,800 $4.34 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $11 Million - $12.3 Million	-109,500 Reduced 84.04%	20,800 $2.27 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.94 Million - $2.28 Million	20,000 Added 18.13%	130,300 $13.2 Million
Q4 2022 Sep 21, 2023	BUY	$95.06 - $111.52 $8.51 Million - $9.98 Million	89,500 Added 430.29%	110,300 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $10.5 Million - $12.3 Million	110,300 New	110,300 $12.1 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.